Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2020 07:00 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Present at Multiple Upcoming Investor Conferences

STAMFORD, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
November 09, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Reports Third Quarter 2020 Financial Results

– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and...
November 02, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Announce Third Quarter 2020 Financial Results on November 9, 2020

STAMFORD, Conn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
October 21, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Announces Presentation at American Society of Nephrology Kidney Week 2020

- Results from global KALM-2 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus to be presented – - NDA submission for KORSUVA Injection on track for fourth quarter...
October 20, 2020 01:00 ET | Source: Cara Therapeutics, Inc.

Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritus

Vifor Pharma secures commercial rights for IV Korsuva in non-Fresenius Medical Care dialysis clinics representing approx. 66% of the market, under a profit-sharing arrangement with CaraCara will...
October 01, 2020 07:00 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer

STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
August 10, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Reports Second Quarter 2020 Financial Results

– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and...
August 06, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference

STAMFORD, Conn., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
August 03, 2020 16:01 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020

STAMFORD, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
June 30, 2020 07:00 ET | Source: Cara Therapeutics, Inc.

Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.

STAMFORD, Conn., June 30, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...